Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptoms of Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01354236
What this trial is testing

Mental Health Related to School Dropout in Luxembourg

Who this might be right for
Anxiety DisordersMood DisordersEating Disorders+4 more
Public Research Centre Health, Luxembourg 200
Not applicableEnded earlyNCT01177709
What this trial is testing

Metformin for Weight Loss in Schizophrenia

Who this might be right for
SchizophreniaObesity
Nathan Kline Institute for Psychiatric Research 12
Not applicableUnknownNCT01832285
What this trial is testing

Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)
Sha'ar Menashe Mental Health Center 40
Not applicableUnknownNCT02221635
What this trial is testing

Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective

Who this might be right for
Schizoaffective Disorder
Xijing Hospital 540
Post-approval studies (Phase 4)UnknownNCT00157378
What this trial is testing

Optimization of Acute Treatment in First Episode Schizophrenia

Who this might be right for
Schizophrenia, First-Episode
Ludwig-Maximilians - University of Munich 300
Post-approval studies (Phase 4)Study completedNCT00034801
What this trial is testing

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Who this might be right for
DepressionSchizophreniaSchizoaffective Disorder
Eli Lilly and Company 378
Post-approval studies (Phase 4)UnknownNCT04020588
What this trial is testing

Anti-inflammatories and Adolescent Schizophrenia

Who this might be right for
Schizophrenia
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 90
Not applicableStudy completedNCT00783120
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia

Who this might be right for
Schizophrenia
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 197
Large-scale testing (Phase 3)UnknownNCT03413527
What this trial is testing

RTMS Treatment for Positive and Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
St. Joseph's Healthcare Hamilton 20
Not applicableStudy completedNCT01202617
What this trial is testing

Seroquel XR in the Long Term Treatment of Schizophrenia

Who this might be right for
Relapse in Schizophrenia
AstraZeneca 1,606
Post-approval studies (Phase 4)Study completedNCT00391261
What this trial is testing

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Cambridge Health Alliance 11
Not applicableStudy completedNCT00903916
What this trial is testing

Effect of Antipsychotics on Appetite Regulation

Who this might be right for
Psychotic Disorders
University of North Carolina, Chapel Hill 45
Large-scale testing (Phase 3)Study completedNCT00300404
What this trial is testing

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Who this might be right for
SchizophreniaMajor Depression
Zentrum für Integrative Psychiatrie 40
Not applicableEnded earlyNCT00203775
What this trial is testing

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Who this might be right for
PsychosisAggression
University of Connecticut
Post-approval studies (Phase 4)Study completedNCT02354001
What this trial is testing

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The Alfred 80
Not applicableStudy completedNCT03818516
What this trial is testing

Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 12
Not applicableUnknownNCT03862209
What this trial is testing

Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia

Who this might be right for
Severe Mental DisorderSchizophreniaBipolar Disorder+1 more
Klinički Bolnički Centar Zagreb 200
Not applicableLooking for participantsNCT05617898
What this trial is testing

Determining the Role of Social Reward Learning in Social Anhedonia

Who this might be right for
Psychosis
University of Alabama at Birmingham 152
Large-scale testing (Phase 3)Study completedNCT05304767
What this trial is testing

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 290
Testing effectiveness (Phase 2)Study completedNCT01488929
What this trial is testing

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Who this might be right for
SchizophreniaNegative SymptomsCognitive Dysfunction
Targacept Inc. 603
Next Page